Development, Reagent and Sales - Clinical Research Informer

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

SEPTEMBER 14, 2022

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development. Technologies in the delivery of peptides and proteins.

Protein

Protein Marketing Manufacturing Reagent

Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives

pharmaphorum

AUGUST 16, 2020

There are profound changes taking place in the area of life science research and development,” stated Swittons CEO and Founder Anupam Nandwana. Reorder reagents. Swittons is powered by the technology and expertise developed by P360. Notify of spill/cleaning needed. Equipment occupancy notification. Re-stock disposable supplies.

Life Science

Life Science Reagent Scientist Clinical Trials

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

DECEMBER 16, 2022

Dopavision, a DTx company in the eye health space, has brought on ophthalmology and neuroscience expert Dirk Sauer , a veteran of Novartis Pharma, to advise the company as it continues to develop MyopiaX, a digital therapeutic for childhood myopia control. AI and robotics hires. McKinnell, Jr. to support the company’s growth.

Behavioural Health

Behavioural Health Reagent Gene Therapy Production

Bio-Techne Announces ISO 13485:2016 Certification for the Woburn, MA Manufacturing Facility

The Pharma Data

OCTOBER 14, 2020

ISO 13485:2016 is an internationally recognized quality standard intended to ensure the consistent design, development, production, installation, and sale of medical devices that are safe for their intended purposes. ” About Bio-Techne Corporation (NASDAQ: TECH). ” About Bio-Techne Corporation (NASDAQ: TECH).

Manufacturing

Manufacturing Reagent Gene Therapy Protein

New Sandoz Board of Directors appointed

The Pharma Data

MAY 15, 2023

The Sandoz Board of Directors will have 10 members in total and 3 sub-committees: a Science, Innovation & Development Committee, a Human Capital & ESG Committee and an Audit, Risk & Compliance Committee. She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company.

Sales

Sales Production Doctors Doctor

Are microtaggants the key to making medicines smarter?

pharmaphorum

JUNE 1, 2021

The dramatic rise in online drug sales during the COVID-19 pandemic has increased the supply of counterfeit drugs, and many companies are now considering the addition of on-dose authentication for high-risk or high-value products. Recent work has concentrated on developing convenient readers to scan information carried on the microtaggants.

Medicine

Medicine DNA Pharmacy Production

National collaboration to support life science sector

Drug Discovery World

MARCH 20, 2024

The Open Access Lab is designed to support start-up life science companies and offers affordable 24-hour access to specialist lab equipment and bench space for businesses working in key research and development areas such as drug discovery, oncology, biotech and pre-clinical trials.

Life Science

Life Science Reagent Clinical Trials Clinical Trials

Avacta Announces Collaboration Agreement With Bruker

The Pharma Data

JANUARY 27, 2021

Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. Beverley, MA) (“Adeptrix”).

Reagent

Reagent In-Vitro FDA Approval Development

The importance of glycan analysis and characterisation for biopharma

Drug Discovery World

OCTOBER 12, 2022

Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents such as monoclonal antibodies and other recombinant proteins.

Protein

Protein Gene Therapy Antibody Production

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

NOVEMBER 1, 2023

Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.

Regulation

Regulation In-Vitro Manufacturing Licensing

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

The Pharma Data

JANUARY 20, 2021

Laboratory Implementation Laboratory reagents for performing the test commercially have been designed and are currently being validated in preparation for regulatory submission to CMS/CLIA with a view to targeting sales in the USA initially. MELBOURNE, Australia, Jan. Key Highlights.

Genetics

Genetics Reagent Biobanking Production

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients

The Pharma Data

SEPTEMBER 7, 2020

The test offers an alternative to lab-developed tests (LDTs) or Analyte Specific Reagent (ASR) combinations, potentially minimising variability and complexity in testing, reducing workload and alleviating risk for laboratories. billion in R&D and posted sales of CHF 61.5 IU/mL and an expanded linear range from 21.5

In-Vitro

In-Vitro Medicine Reagent DNA

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients

The Pharma Data

AUGUST 4, 2020

The test offers an alternative to lab-developed tests (LDTs) or Assay Specific Reagents (ASR) combinations, potentially minimising variability and complexity in testing, reducing workload and alleviating risk for laboratories. billion in R&D and posted sales of CHF 61.5 In 2019, Roche invested CHF 11.7

DNA

DNA In-Vitro Medicine Reagent

Clinical Research Informer

Leading API biologics (protein and peptide) companies in contract marketing

Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives

Trending Sources

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

Bio-Techne Announces ISO 13485:2016 Certification for the Woburn, MA Manufacturing Facility

New Sandoz Board of Directors appointed

Are microtaggants the key to making medicines smarter?

National collaboration to support life science sector

Avacta Announces Collaboration Agreement With Bruker

The importance of glycan analysis and characterisation for biopharma

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients

Stay Connected